CoreAge Rx vs vyrarx

The verdict for women

CoreAge Rx edges out vyrarx on the Metabolic-Fit Score, 86 to 34 (B vs C). Someone considering both compounded injection options who wants an advertised flat price without a required subscription and will confirm the exact prescription, state access and refund terms.

vyrarx is still a genuine option — publishes a floor and calls it a price: the site says "From $179 /mo" for semaglutide and "From $329 /mo" for tirzepatide, and the word from is doing real work in both. No dose ladder, no maintenance rate and no ceiling appear anywhere on the public site, which means the number you would actually pay once you titrate up is the one piece of information the page does not give you. That matters more here than on a flat-price seller, because a floor tells you only where the billing starts. On the disclosure side it does better than several listings here: it names its operating entity, vyrarx, Inc., in its own Terms, and it has no FDA warning letter. No state list is published, and nothing on the site addresses pregnancy, breastfeeding or postpartum timing. Weigh the six women's-health factors below against your own priorities.